New insights into cartilage repair - The role of migratory progenitor cells in osteoarthritis

Matrix Biology

Volumn 31, Issue 3, 2012, Pages 206-213

  Gerter, Regina ^a   Kruegel, Jenny ^a   Miosge, Nicolai ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chondrogenic progenitor cells; Cytokine; Extracellular matrix; Mesenchymal stem cells; Osteoarthritis

Indexed keywords

CARTILAGE; CARTILAGE CELL; CELL MIGRATION; CELL REGENERATION; CHONDROGENESIS; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE REGENERATION;

CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELL MOVEMENT; CHONDROCYTES; CHONDROGENESIS; EXTRACELLULAR MATRIX; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; OSTEOARTHRITIS; PERICYTES; REGENERATION;

EID: 84857794211     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2012.01.007     Document Type: Review

References (81)

1. Ahmed T.A., Hincke M.T. Strategies for articular cartilage lesion repair and functional restoration. Tissue Eng. Part B Rev. 2010, 16:305-329.
2. Aigner T., McKenna L. Molecular pathology and pathobiology of osteoarthritic cartilage. Cell. Mol. Life Sci. 2002, 59:5-18.
3. Alsalameh S., Amin R., Gemba T., Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 2004, 50:1522-1532.
4. Aplin A.E., Juliano R.L. Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway. J. Cell Sci. 1999, 112(Pt 5):695-706.
5. Appleton C.T., James C.G., Beier F. Regulator of G-protein signaling (RGS) proteins differentially control chondrocyte differentiation. J. Cell. Physiol. 2006, 207:735-745.
6. Belvisi M.G., Bottomley K.M. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?. Inflamm. Res. 2003, 52:95-100.
7. Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne R., Rorabeck C., Mitchell P., Hambor J., Diekmann O., Tschesche H., Chen J., Van Wart H., Poole A.R. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J. Clin. Invest. 1997, 99:1534-1545.
8. Blaney Davidson E.N., Vitters E.L., van der Kraan P.M., van den Berg W.B. Expression of transforming growth factor-β (TGFβ) and the TGFβ signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann. Rheum. Dis. 2006, 65:1414-1421.
9. Blaney Davidson E.N., Vitters E.L., van den Berg W.B., van der Kraan P.M. TGFβ-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7. Arthritis Res. Ther. 2006, 8:R65-R72.
10. Blum B., Benvenisty N. Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells 2007, 25:1924-1930.
11. Bobacz K., Gruber R., Soleiman A., Erlacher L., Smolen J.S., Graninger W.B. Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis Rheum. 2003, 48:2501-2508.
12. Brennan F.M., McInnes I.B. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 2008, 118:3537-3545.
13. Buma P., Pieper J.S., van Tienen T., van Susante J.L., van der Kraan P.M., Veerkamp J.H., van den Berg W.B., Veth R.P., van Kuppevelt T.H. Cross-linked type I and type II collagenous matrices for the repair of full-thickness articular cartilage defects-a study in rabbits. Biomaterials 2003, 24:3255-3263.
14. Cai J., Kehoe O., Smith G.M., Hykin P., Boulton M.E. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2008, 49:2163-2171.
15. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 2007, 213:341-347.
16. Caplan A.I. New era of cell-based orthopedic therapies. Tissue Eng. Part B Rev. 2009, 15:195-200.
17. Chen C.C., Young J.L., Monzon R.I., Chen N., Todorovic V., Lau L.F. Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. EMBO J. 2007, 26:1257-1267.
18. Cheng A., Genever P.G. SOX9 determines RUNX2 transactivity by directing intracellular degradation. J. Bone Miner. Res. 2010, 25:2680-2689.
19. Chia S.L., Sawaji Y., Burleigh A., McLean C., Inglis J., Saklatvala J., Vincent T. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 2009, 60:2019-2027.
20. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J., Peault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
21. de Crombrugghe B., Lefebvre V., Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr. Opin. Cell Biol. 2001, 13:721-727.
22. Doherty M.J., Ashton B.A., Walsh S., Beresford J.N., Grant M.E., Canfield A.E. Vascular pericytes express osteogenic potential in vitro and in vivo. J. Bone Miner. Res. 1998, 13:828-838.
23. Dowthwaite G.P., Bishop J.C., Redman S.N., Khan I.M., Rooney P., Evans D.J., Haughton L., Bayram Z., Boyer S., Thomson B., Wolfe M.S., Archer C.W. The surface of articular cartilage contains a progenitor cell population. J. Cell Sci. 2004, 117:889-897.
24. Enomoto-Iwamoto M., Iwamoto M., Nakashima K., Mukudai Y., Boettiger D., Pacifici M., Kurisu K., Suzuki F. Involvement of alpha5beta1 integrin in matrix interactions and proliferation of chondrocytes. J. Bone Miner. Res. 1997, 12:1124-1132.
25. Farrington-Rock C., Crofts N.J., Doherty M.J., Ashton B.A., Griffin-Jones C., Canfield A.E. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004, 110:2226-2232.
26. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39:237-246.
27. Fickert S., Fiedler J., Brenner R.E. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res. Ther. 2004, 6:R422-R432.
28. Fuchs E., Tumbar T., Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004, 116:769-778.
29. Fujisato T., Sajiki T., Liu Q., Ikada Y. Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold. Biomaterials 1996, 17:155-162.
30. Fukui N., Zhu Y., Maloney W.J., Clohisy J., Sandell L.J. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J. Bone Joint Surg. Am. 2003, 85-A(Suppl 3):59-66.
31. Goldring S.R., Goldring M.B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. 2004, S27-36.
32. Harvey A.K., Hrubey P.S., Chandrasekhar S. Transforming growth factor-beta inhibition of interleukin-1 activity involves down-regulation of interleukin-1 receptors on chondrocytes. Exp. Cell Res. 1991, 195:376-385.
33. Hedbom E., Hauselmann H.J. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell. Mol. Life Sci. 2002, 59:45-53.
34. Heida N.M., Muller J.P., Cheng I.F., Leifheit-Nestler M., Faustin V., Riggert J., Hasenfuss G., Konstantinides S., Schafer K. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J. Am. Coll. Cardiol. 2010, 55:357-367.
35. Hidaka C., Goldring M.B. Regulatory mechanisms of chondrogenesis and implications for understanding articular cartilage homeostasis. Curr. Rheumatol. Rev. 2008, 4(3):136-147.
36. Hing W.A., Sherwin A.F., Ross J.M., Poole C.A. The influence of the pericellular microenvironment on the chondrocyte response to osmotic challenge. Osteoarthr. Cartil. 2002, 10:297-307.
37. Hoekstra R., Eskens F.A., Verweij J. Matrix metalloproteinase inhibitors: current developments and future perspectives. Oncologist 2001, 6:415-427.
38. Horton W.E., Bennion P., Yang L. Cellular, molecular, and matrix changes in cartilage during aging and osteoarthritis. J. Musculoskelet. Neuronal. Interact. 2006, 6:379-381.
39. Huch K., Wilbrink B., Flechtenmacher J., Koepp H.E., Aydelotte M.B., Sampath T.K., Kuettner K.E., Mollenhauer J., Thonar E.J. Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta. Arthritis Rheum. 1997, 40:2157-2161.
40. Iozzo R.V., Pillarisetti J., Sharma B., Murdoch A.D., Danielson K.G., Uitto J., Mauviel A. Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element. J. Biol. Chem. 1997, 272:5219-5228.
41. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 1998, 238:265-272.
42. Knudson W., Loeser R.F. CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell. Mol. Life Sci. 2002, 59:36-44.
43. Knutsen G., Engebretsen L., Ludvigsen T.C., Drogset J.O., Grontvedt T., Solheim E., Strand T., Roberts S., Isaksen V., Johansen O. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J. Bone Joint Surg. Am. 2004, 86-A:455-464.
44. Koelling S., Miosge N. Stem cell therapy for cartilage regeneration in osteoarthritis. Expert. Opin. Biol. Ther. 2009, 9:1399-1405.
45. Koelling S., Miosge N. Sex differences of chondrogenic progenitor cells in late stages of osteoarthritis. Arthritis Rheum. 2010, 62:1077-1087.
46. Koelling S., Clauditz T.S., Kaste M., Miosge N. Cartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritis. Arthritis Res. Ther. 2006, 8:R56.
47. Koelling S., Kruegel J., Irmer M., Path J.R., Sadowski B., Miro X., Miosge N. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell 2009, 4:324-335.
48. Kruegel J., Sadowski B., Miosge N. Nidogen-1 and nidogen-2 in healthy human cartilage and in late-stage osteoarthritis cartilage. Arthritis Rheum. 2008, 58:1422-1432.
49. Kuettner K.E. Biochemistry of articular cartilage in health and disease. Clin. Biochem. 1992, 25:155-163.
50. Lawrence R.C., Helmick C.G., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., Heyse S.P., Hirsch R., Hochberg M.C., Hunder G.G., Liang M.H., Pillemer S.R., Steen V.D., Wolfe F. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998, 41:778-799.
51. Lee C.R., Grodzinsky A.J., Hsu H.P., Spector M. Effects of a cultured autologous chondrocyte-seeded type II collagen scaffold on the healing of a chondral defect in a canine model. J. Orthop. Res. 2003, 21:272-281.
52. Loeser R.F. Integrins and cell signaling in chondrocytes. Biorheology 2002, 39:119-124.
53. Lohmander L.S., Roos E.M. Clinical update: treating osteoarthritis. Lancet 2007, 370:2082-2084.
54. Malicev E., Radosavljevic D., Velikonja N.K. Fibrin gel improved the spatial uniformity and phenotype of human chondrocytes seeded on collagen scaffolds. Biotechnol. Bioeng. 2007, 96:364-370.
55. McNickle A.G., L'Heureux D.R., Yanke A.B., Cole B.J. Outcomes of autologous chondrocyte implantation in a diverse patient population. Am. J. Sports Med. 2009, 37:1344-1350.
56. McQuillan D.J., Handley C.J., Campbell M.A., Bolis S., Milway V.E., Herington A.C. Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage. Biochem. J. 1986, 240:423-430.
57. Miosge N., Hartmann M., Maelicke C., Herken R. Expression of collagen type I and type II in consecutive stages of human osteoarthritis. Histochem. Cell Biol. 2004, 122:229-236.
58. Miyamoto S., Teramoto H., Gutkind J.S., Yamada K.M. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 1996, 135:1633-1642.
59. Murphy J.M., Dixon K., Beck S., Fabian D., Feldman A., Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 2002, 46:704-713.
60. Naito K., Takahashi M., Kushida K., Suzuki M., Ohishi T., Miura M., Inoue T., Nagano A. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford) 1999, 38:510-515.
61. Nicolae C., Olsen B.R. Unexpected matrix diseases and novel therapeutic strategies. Cell Tissue Res. 2010, 339:155-165.
62. Noth U., Rackwitz L., Heymer A., Weber M., Baumann B., Steinert A., Schutze N., Jakob F., Eulert J. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels. J. Biomed. Mater. Res. A 2007, 83:626-635.
63. Parsons J.T., Horwitz A.R., Schwartz M.A. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 2010, 11:633-643.
64. Polur I., Lee P.L., Servais J.M., Xu L., Li Y. Role of HTRA1, a serine protease, in the progression of articular cartilage degeneration. Histol. Histopathol. 2010, 25:599-608.
65. Pridie K.H. The development and nature of osteoarthritis of the hip joint. Rheumatism 1955, 11:2-7.
66. Pufe T., Petersen W., Tillmann B., Mentlein R. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J. Rheumatol. 2001, 28:1482-1485.
67. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., Horwitz A.R. Cell migration: integrating signals from front to back. Science 2003, 302:1704-1709.
68. Rotundo R.F., Curtis T.M., Shah M.D., Gao B., Mastrangelo A., LaFlamme S.E., Saba T.M. TNF-alpha disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L316-L329.
69. Shi S., Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J. Bone Miner. Res. 2003, 18:696-704.
70. Simon T.M., Jackson D.W. Articular cartilage: injury pathways and treatment options. Sports Med. Arthrosc. 2006, 14:146-154.
71. Solchaga L.A., Penick K., Goldberg V.M., Caplan A.I., Welter J.F. Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng. Part A 2010, 16:1009-1019.
72. Sun H.B. Mechanical loading, cartilage degradation, and arthritis. Ann. N. Y. Acad. Sci. 2010, 1211:37-50.
73. Turner M., Chantry D., Katsikis P., Berger A., Brennan F.M., Feldmann M. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur. J. Immunol. 1991, 21:1635-1639.
74. Tyler J.A. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem. J. 1989, 260:543-548.
75. Ueki Y., Lin C.Y., Senoo M., Ebihara T., Agata N., Onji M., Saheki Y., Kawai T., Mukherjee P.M., Reichenberger E., Olsen B.R. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice. Cell 2007, 128:71-83.
76. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., van den Berg W.B. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthr. Cartil. 2000, 8:25-33.
77. van der Kraan P.M., Blaney Davidson E.N., Blom A., van den Berg W.B. TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis. Osteoarthr. Cartil. 2009, 17:1539-1545.
78. van Horssen R., Galjart N., Rens J.A., Eggermont A.M., ten Hagen T.L. Differential effects of matrix and growth factors on endothelial and fibroblast motility: application of a modified cell migration assay. J. Cell. Biochem. 2006, 99:1536-1552.
79. Xu L., Servais J., Polur I., Kim D., Lee P.L., Chung K., Li Y. Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. Arthritis Rheum. 2010, 62:2736-2744.
80. Yaeger P.C., Masi T.L., de Ortiz J.L., Binette F., Tubo R., McPherson J.M. Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp. Cell Res. 1997, 237:318-325.
81. Yan J., Qi N., Zhang Q. Rabbit articular chondrocytes seeded on collagen-chitosan-GAG scaffold for cartilage tissue engineering in vivo. Artif. Cells Blood Substit. Immobil. Biotechnol. 2007, 35:333-344.